Quiver Bioscience

Decoding Brain Disease to Reimagine Drug Development

[Quiver Bioscience @QuiverBio]

Tx dev. for the brain is hard. Billions of connected cells create an information problem. How do we capture all the complex info necessary to dev. treatments? Q-State Bio is equipped to address this challenge with our BRITE™️ system, which paints a unique picture of CNS disease.

[Quiver Bioscience @QuiverBio]

Quiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In Silico Predictor of CNS Drug Safety - https://t.co/zy97v1P3ru

[Quiver Bioscience @QuiverBio]

Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X Syndrome - https://t.co/0YRlaYt2FP

[Quiver Bioscience @QuiverBio]

We are looking forward to participating at the @AmEpilepsySoc Annual Meeting #AES2024 in Los Angeles! Stop by our poster to learn more about how we are supporting drug development with collaborators at @biohaven !

[Quiver Bioscience @QuiverBio]

📣 | News Alert!
📰 | Press Release: https://t.co/pj7RTuMWgc

📰 Check out the full text publication here: https://t.co/qjYkaFGeT1

#drugdiscovery #FXS #ML #neuroscience #FragileX

[Quiver Bioscience @QuiverBio]

We are excited to welcome Sudhir Agrawal D.Phil, FRSC as a member of our Scientific Advisory Board!

Welcome to our team Sudhir, we look forward to working together and thank you for supporting Quiver’s mission to transform CNS drug discovery!

[Quiver Bioscience @QuiverBio]

We are excited to welcome Alan Kopin as a member of our Scientific Advisory Board!

Welcome to our team Alan, we look forward to working together and thank you for supporting Quiver’s mission to transform CNS drug discovery!

[Quiver Bioscience @QuiverBio]

Our Founder and CSO, Graham Dempsey, will be speaking Tuesday April 2nd at the 2nd International Conference on Artificial Intelligence in Epilepsy and Neurological Disorders. Please reach out if you are also attending and would like to connect!

#epilepsy #ILAE #neuroscience #AI

[Quiver Bioscience @QuiverBio]

We are excited to welcome Anne Carpenter as a member of our Scientific Advisory Board!

Welcome to our team Anne, we look forward to working together and thank you for supporting Quiver’s mission to transform CNS drug discovery!

[Quiver Bioscience @QuiverBio]

We are excited to welcome Adam Cohen as a member of our Scientific Advisory Board!

Welcome to our team Adam, we look forward to continuing our work together and thank you for supporting Quiver’s mission to transform CNS drug discovery!

[Quiver Bioscience @QuiverBio]

We are excited to welcome Giorgia Quadrato as a member of our Scientific Advisory Board!

Welcome to our team Giorgia, we look forward to working together and thank you for supporting Quiver’s mission to transform CNS drug discovery!

[Quiver Bioscience @QuiverBio]

Check out our recently published study in Pain - "A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology"

https://t.co/SPdQCzQMCt

#pain #neuroscience #DrugDevelopment

[Quiver Bioscience @QuiverBio]

Today we are celebrating 1 Year as Quiver Bioscience! We look back on this year with pride for all we have accomplished and look forward to great things in store, as we strive to transform the process of drug discovery for CNS disorders.
#Neuroscience #drugdiscovery

[Quiver Bioscience @QuiverBio]

Quiver Bioscience is excited to be supporting Angelini Pharma in their research and development efforts on epilepsy therapeutics.

#epilepsy #drugdiscovery #drugdevelopment #neuroscience

[Quiver Bioscience @QuiverBio]

This week is KCNQ2 Awareness Week! Quiver is proud to help raise awareness around KCNQ2 epilepsy. Please help spread awareness by liking and sharing this post. To learn more about KCNQ2 epilepsy, please visit: https://t.co/oM9KjtfWXq
#epilepsy #kcnq2awareness #RareDisease

[Quiver Bioscience @QuiverBio]

Quiver is proud to have been the lead sponsor for the Dup15q “Believe in a Cure” Gala this past weekend! Quiver is proud to support this mission and we look forward to working shoulder-to-shoulder with the Dup15q Alliance as we advance our ASO program towards the clinic.#dup15q

[Quiver Bioscience @QuiverBio]

Discovery of novel compounds and target mechanisms using a high throughput, multiparametric phenotypic screen in a human neuronal model of Tuberous Sclerosis https://t.co/7xWkm5UZmk

[Quiver Bioscience @QuiverBio]

We’re proud to announce our name change to Quiver Bioscience. After a decade of scientific advancements, we've re-branded to reflect our expanded focus on delivering #therapeutics for neurological disease from target to clinic - and continued commitment to expand human health.

[Quiver Bioscience @QuiverBio]

@cureSYNGAP1 Yes! Head on over to our Linkedin!

[Quiver Bioscience @QuiverBio]

Q-State is headed to the @AmEpilepsySoc (AES) Annual Meeting in Nashville next week! We will present on therapeutic programs across genetic epilepsies that are uniquely powered by our platform: UBE3A/Dup15q, DEE13/SCN8A, KCNT1, KCNQ2, STXBP1, SYNGAP1 and Tuberous Sclerosis. (1/3)